
AZ checkpoint blocker combo fails in head and neck cancer
It's another setback for combinations of checkpoint inhibitors as treatments of cancer; following a recent failure of a combo of AstraZeneca's PD-L1...

uniqure delivers POC for hemophilia B gene therapy
AMT-061, an AAV5 vector, expresses a gene cassette with the Padua variant of Factor IX, which lacks in hemophilia B patients. According to uniqure,...

Drug dissociates metastasis precursors in blood
In Cell, the team headed by Nicola Aceto from University Hospital Basel, Switzerland, reported that a screening of 2,486 FDA-approved...

Uncommon mutations affect breast cancer prognosis
Patients with oestrogen receptor positive breast cancer often relapse after 5 years of later. To find out more the researchers applied targeted...

Afyren raises €21m to launch production plant
Together with its historical shareholders AFY Partners and Sofimac Régions Afyren has raised more than €60m to move its zero-waste fermentation...


BioFIT: innovation and investors
Around 1.500 people came to Lille to participate in the event. BioFIT is hitting a nerve, says Etienne Varvaecke. The general manager of Eurosanté,...

Medicxi put €40m into two Sosei spin off companies
The newly created companies Orexia Ltd and Inexia Ltd aim to develop orally or intranasally administered drug candidates to treat...